Drugs for non-HIV viral infections

Medical Letter on Drugs and Therapeutics

Volumn 39, Issue 1006, 1997, Pages 69-76

  Abramowicz, Mark ^f   Rizack, Martin A ^a   Goodstein, Donna ^f   Faucard, Amy ^f   Hansten, Philip D ^b   Steigbigel, Neal H ^c   Mukherjee, Sandip K ^d   Smoller, Jordan W ^e   Zuccotti, Gianna ^c   Aschenbrenner, Marianne ^f  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ALPHA2A INTERFERON; ALPHA2B INTERFERON; AMANTADINE; ANTIVIRUS AGENT; CIDOFOVIR; FAMCICLOVIR; FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR; LAMIVUDINE; PENCICLOVIR; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; RIMANTADINE; TRIFLURIDINE; VALACICLOVIR;

AGED; CLINICAL TRIAL; CYTOMEGALOVIRUS; DRUG CHOICE; DRUG COST; DRUG INFORMATION; DRUG RESISTANCE; EDEMA; GASTROINTESTINAL SYMPTOM; HEADACHE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS; HUMAN; INFLUENZA VIRUS A; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; ORAL DRUG ADMINISTRATION; RASH; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

2-AMINOPURINE; ABNORMALITIES, DRUG-INDUCED; ACYCLOVIR; AMANTADINE; ANTIVIRAL AGENTS; CYTOSINE; DRUG RESISTANCE, MICROBIAL; EYE INFECTIONS, VIRAL; FOSCARNET; GANCICLOVIR; HUMANS; INTERFERON-ALPHA; KIDNEY DISEASES; LAMIVUDINE; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; PRODRUGS; RIBAVIRIN; RIMANTADINE; TRIFLURIDINE; VALINE; VIRUS DISEASES;

EID: 1842405948     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (41)

1. A Wald et al, J Clin Invest, 99:1092, March 1997
2. Medical Letter, 39:15, 1997
3. G Blick et al, J Acquir Immune Defic Syndr Hum Retrovirol, 15:84, 1997
4. J Lalezari et al, J Infect Dis, 1997, in press
5. Medical Letter, 36:97, 1994
6. S Tyring et al, Ann Intern Med, 123:89, 1995
7. M Loveless et al, Intersci Conf Antimicrob Agents Chemother, 35:181, 1995; SL Sacks et al, JAMA, 276:44, 1996; GJ Mertz et al, Arch Intern Med, 157:343, 1997
8. M Loveless et al, Intersci Conf Antimicrob Agents Chemother, 35:181, 1995; SL Sacks et al, JAMA, 276:44, 1996; GJ Mertz et al, Arch Intern Med, 157:343, 1997
9. M Loveless et al, Intersci Conf Antimicrob Agents Chemother, 35:181, 1995; SL Sacks et al, JAMA, 276:44, 1996; GJ Mertz et al, Arch Intern Med, 157:343, 1997
10. T Schacker et al, Ann Intern Med, in press, 1997
11. C Trepo et al, J Hepatol, 26 suppl 1:74, 1997
12. CM Perry and AJ Wagstaff, Drugs, 50:396, 1995
13. SL Sacks et al, Antiviral Res, 23 suppl 1:72, 1994
14. Medical Letter, 34:3, 1992
15. Studies of Ocular Complications of AIDS Research Group, Arch Ophthalmol, 114:23, 1996
16. MA Jacobsen, N Engl J Med, 337:105, July 10, 1997; DC Musch et al, N Engl J Med, 337:83, July 10, 1997
17. MA Jacobsen, N Engl J Med, 337:105, July 10, 1997; DC Musch et al, N Engl J Med, 337:83, July 10, 1997
18. C Crumpacker et al, N Engl J Med, 335:721, 1996
19. AD Badley et al, Transplantation, 64:1, July 15, 1997
20. C Niederau et al N Engl J Med, 334:1422, 1996
21. P Farci et al, N Engl J Med, 330:88, 1994
22. S Brillanti et al, Gastroenterology, 107: 812, 1994; M-Y Lai et al, Gastroenterology, 111:1307, 1996
23. S Brillanti et al, Gastroenterology, 107: 812, 1994; M-Y Lai et al, Gastroenterology, 111:1307, 1996
24. Y Kanda et al, Lancet, 343:1134, 1994
25. JL Dienstag et al, N Engl J Med, 333:1657, 1995
26. CL Lai et al, J Hepatol, 26 supp. 1:79, 1997
27. L Grellier et al, Lancet, 348:1212, 1996; MM Bartholomew et al. Lancet, 349:20, 1997; SW Schalm et al, Lancet, 349:3, 1997
28. L Grellier et al, Lancet, 348:1212, 1996; MM Bartholomew et al. Lancet, 349:20, 1997; SW Schalm et al, Lancet, 349:3, 1997
29. L Grellier et al, Lancet, 348:1212, 1996; MM Bartholomew et al. Lancet, 349:20, 1997; SW Schalm et al, Lancet, 349:3, 1997
30. Medical Letter 39:57, 1997
31. SL Spruance et al, JAMA, 277:1374, May 7, 1997
32. Committee on Infectious Diseases, Pediatrics, 97:137, 1996
33. AM Di Bisceglie et al, Ann Intern Med 123:897 1995
34. S Brillanti et al, Gastroenterology, 107:812, 1994; M-Y Lai et al, Gastroenterology, 111:1307, 1996
35. S Brillanti et al, Gastroenterology, 107:812, 1994; M-Y Lai et al, Gastroenterology, 111:1307, 1996
36. JB McCormick et al, N Engl J Med, 314:20, 1986; JW Huggins et al, J Infect Dis, 164:1119, 1991
37. JB McCormick et al, N Engl J Med, 314:20, 1986; JW Huggins et al, J Infect Dis, 164:1119, 1991
38. G Mertz and L Chapman, Adv Exp Med Biol, 394:153, 1996
39. Medical Letter, 38:3, 1996
40. KR Beutner et al, Antimicrob Agents Chemother, 39:1546, 1995
41. J Feinberg et al, Intersci Conf Antimicrob Agents Chemother, 35:243, 1995